Search the Community
Showing results for tags 'Cabazitaxel'.
JimJimJimJim posted a topic in Articles on other sitesJim Marshall (not a doctor) said ... The clinical trial testing Lutetium-177 therapy against the existing standard therapy (Cabazitaxel (Jevtana)) is taking its first men. It starts at the Peter MacCallum Cancer Center in Melbourne (PeterMac), and other sites will be progressively added. The Prostate Cancer Foundation of Australia (PCFA), with which we are affiliated, has co-sponsored the trial. Below is the message that Daniel Moore of PCFA sent announcing the start. ... end Jim In July 2017 PCFA and ANZUP launched the first Australian trial of a ground-breaking
This news from member Ian about his sixtieth (yes 60th - 20 Taxotere (Docetaxel)+ 40 Jevtana (Cabazitaxel)) chemotherapy session was held up a couple of weeks. [Sorry about the delay - Jim]. Hi Jim,Just got results of CT & Bone scan. A little new metastatis, some existing disappeared altogether, some reduced 25%, some 10%. An overall good result considering I was diagnosed in 2002.Continuing with chemo number 60 tomorrow.Kind regards,Ian
Cabazitaxel is a chemotherapy treatment which is used when patients become resistant to chemotherapy treatment with Docetaxel. Cabazitaxel improves overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with Docetaxel. Androgen receptor splice variant 7 (AR-V7) in circulating tumuor cells (CTCs) from mCRPC patients was recently demonstrated to be associated with resistance to Abiraterone and Enzalutamide. A group of Dutch and Belgian researchers investigated whether this was also true for Cabazitaxel. They found that Cabazitax